Transforming Drug Discovery through Genomics and Proteomics

March 31, 2009 - PRLog -- Phoenix, AZ - “Transforming Drug Discovery through Genomics and Proteomics,” a report published by Pharma-Reports.com, looks at how advances in genomics and proteomics are transforming the landscape of drug discovery and drug development.

Genomics is a science that studies the structure and function of genomes and, in particular, genes. A genome is an organism’s complete genetic signature. It is the palate of information an organism can call on in order to ensure its own survival and growth. Meanwhile, proteomics is essentially protein analysis. It is typically associated with systems biology. Powerful new technologies for differential complexity reduction are expected to solve some of the most pressing problems in drug development.

The report analyzes the basics and processes of both genomics and proteomics, the various technologies involved in the process of drug development, genomics and proteomics. The report aids in the understanding of drug development with the help of genomics and proteomics.

Other Topics covered in this report include: Genomics & Implications of the Human Genome Project; Proteomics Processes; Regulatory Approval of Pharmaceuticals; and Future Outlook for the Drug Discovery Market.

About the Publisher: "Transforming Drug Discovery Through Genomics and Proteomics " is published by Pharma-Reports (www.Pharma-Reports.com), a pharmaceutical and biotechnology industry think tank and leading source for pharmaceutical and biotechnology industry information and research products.  View details of this report at http://www.pharma-reports.com/shop/item.asp?itemid=8&affi...

# # #

Pharma-Reports publishes Cutting-edge business research and analysis reports in the pharmaceutical and biotech industries.